Researchers at MIT have used two experimental cancer drugs in tandem to fight melanomas. The team paired protein kinase inhibitors with ribonuclease drugs and set them loose onto tumors, and found that the combination worked better than either drug does alone. The discovery could help reduce side effects of cancer treatments and make them more effective.